![Julien Alberici](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julien Alberici
Vorstandsvorsitzender bei
Mathym SAS
Profil
Julien Alberici is the founder.
Founded Mathym SAS in 2013 as Chief Executive Officer.
Current job at Octalfa SAS since 2013 as CEO.
Current job at ORPHELIA Pharma SAS as Director.
Former job at Baikowski SA as Director-Business Development.
Aktive Positionen von Julien Alberici
| Unternehmen | Position | Beginn |
|---|---|---|
Octalfa SAS
 Octalfa SAS Investment ManagersFinance Octalfa is a hands-on investor who plays an active role in their portfolio companies and seeks board representation. The firm focuses on early-stage businesses including seed-stage projects in the life sciences sectors, and may also co-invest in later-stage companies. Octalfa invests from their own balance sheet, in the EUR 500 thousand to 1.5 million range, as a one-time investor or over several financing rounds. | Verwaltungsdirektor | 01.01.2013 |
Mathym SAS
 Mathym SAS Miscellaneous Commercial ServicesCommercial Services Manufacutures and developps innovative colloïdal solutions. | Vorstandsvorsitzender | 01.09.2013 |
ORPHELIA Pharma SAS
 ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Julien Alberici
| Unternehmen | Position | Ende |
|---|---|---|
| BAIKOWSKI | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Octalfa SAS
Octalfa SAS Investment ManagersFinance Octalfa is a hands-on investor who plays an active role in their portfolio companies and seeks board representation. The firm focuses on early-stage businesses including seed-stage projects in the life sciences sectors, and may also co-invest in later-stage companies. Octalfa invests from their own balance sheet, in the EUR 500 thousand to 1.5 million range, as a one-time investor or over several financing rounds. | Finance |
Mathym SAS
Mathym SAS Miscellaneous Commercial ServicesCommercial Services Manufacutures and developps innovative colloïdal solutions. | Commercial Services |
Baikowski SA
 Baikowski SA Chemicals: SpecialtyProcess Industries Produces and supplies alumina powders, phosphors & formulations | Process Industries |
ORPHELIA Pharma SAS
ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children | Health Technology |
